The ever-expanding wide spectrum of treatment options for ASCVD has drastically changed the lipid-lowering landscape. Understanding the nuanced considerations for patient selection is now more important than ever. Join the experts to hear the latest strategies on appropriately using new nonstatin agents in clinical practice.
We are grateful to these distinguished Members of the American College of Cardiology who contributed to this collection:Salim Virani, MD, FACCVera Bittner, MD, FACCKim Birtcher, PharmD, AACCKeith Ferdinand, MD, FACCMahmoud Al Rifai, MD, MPH